Literature DB >> 7493166

A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis.

D R Booth1, S Y Tan, S E Booth, J J Hsuan, N F Totty, O Nguyen, T Hutton, D M Vigushin, G A Tennent, W L Hutchinson.   

Abstract

A man with hereditary non-neuropathic systemic amyloidosis had amyloid fibril protein subunits consisting of N-terminal fragments (residues 1-86, 1-92 and 1-93) of a previously unknown variant of apolipoprotein Al, Trp50Arg, encoded by a thymine-cytosine transition. This is the third reported amyloidogenic apoAl variant. All involve substitutions of single neutral amino acids by the cationic residue arginine, suggesting a common mechanism of amyloidogenesis. However, the phenotypic expression of these mutations varies both within and between the seven known families with hereditary apoAl amyloidosis. These findings should facilitate analysis of the molecular basis of fibrillogenesis and of factors that modulate amyloid deposition and its consequences in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493166

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  17 in total

1.  Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure.

Authors:  P Mangione; M Sunde; S Giorgetti; M Stoppini; G Esposito; L Gianelli; L Obici; L Asti; A Andreola; P Viglino; G Merlini; V Bellotti
Journal:  Protein Sci       Date:  2001-01       Impact factor: 6.725

Review 2.  A novel amyloidogenic variant of apolipoprotein AI: implications for a conformational change leading to cardiomyopathy.

Authors:  M T Walsh
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

3.  Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis.

Authors:  M M de Sousa; C Vital; D Ostler; R Fernandes; J Pouget-Abadie; D Carles; M J Saraiva
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation.

Authors:  Nicole K Andeen; Daniel Y Lam; Ian H de Boer; Roberto F Nicosia
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

5.  Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.

Authors:  Dorota Rowczenio; Ahmet Dogan; Jason D Theis; Julie A Vrana; Helen J Lachmann; Ashutosh D Wechalekar; Janet A Gilbertson; Toby Hunt; Simon D J Gibbs; Prayman T Sattianayagam; Jenny H Pinney; Philip N Hawkins; Julian D Gillmore
Journal:  Am J Pathol       Date:  2011-08-05       Impact factor: 4.307

6.  Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.

Authors:  D R Booth; S Y Tan; S E Booth; G A Tennent; W L Hutchinson; J J Hsuan; N F Totty; O Truong; A K Soutar; P N Hawkins; M Bruguera; J Caballería; M Solé; J M Campistol; M B Pepys
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 7.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

8.  Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis.

Authors:  Julian D Gillmore; Helen J Lachmann; Dorota Rowczenio; Janet A Gilbertson; Cai-Hong Zeng; Zhi-Hong Liu; Lei-Shi Li; Ashutosh Wechalekar; Philip N Hawkins
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

9.  Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.

Authors:  Magdalena Eriksson; Stefan Schönland; Saniye Yumlu; Ute Hegenbart; Hanna von Hutten; Zarina Gioeva; Peter Lohse; Janine Büttner; Hartmut Schmidt; Christoph Röcken
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

10.  Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.

Authors:  Madhurima Das; Xiaohu Mei; Shobini Jayaraman; David Atkinson; Olga Gursky
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.